Search Results
Results found for "Sosei Heptares"
- Dr. Chris Tate | Dr. GPCR Ecosystem
Join me to learn more about Chris’s work and his role in founding Heptares which was later acquired by Sosei and became Sosei Heptares . Chris Tate on the web LinkedIn ResearchGate Pubmed Google Scholar Sosei Heptares Wikipedia MRC Laboratory
- Annabelle Milner | Dr. GPCR Ecosystem
Alastair Brown (Sosei Heptares), where she is currently a final year Ph.D. student.
- Dr. Fiona Marshall: Three Decades Inside GPCR Drug Discovery | Dr. GPCR Ecosystem
Chris Tate's thermostabilization strategy finally made GPCR structures routine, the insight that seeded Heptares She co-founded Heptares Therapeutics and served as Chief Scientific Officer for twelve years, through the company's acquisition by Sosei, helping establish structure-based drug design as a productive strategy β-adrenergic signaling set a career in motion 07:07 A venture capital visit to the LMB and the founding of Heptares As a co-founder of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery
- Chris Langmead | Dr. GPCR Ecosystem
Prior to these roles this he was Head of Pharmacology at Heptares Therapeutics Ltd., a UK-based biotechnology These successes enabled the US$400M sale of Heptares Therapeutics Ltd. to the Sosei Group Corporation Prior to joining Heptares, Chris was a neuroscience researcher at GlaxoSmithKline, UK (1998-2009).
